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Q102R AND Q203L DOUBLE MUTANT EFFECTS ON SUBSTRATE 
SPECIFICTY AND ACTIVATOR REQUIREMENT IN bsLDH ENZYME 
SUMMARY 
Enzymes are biological catalysts that play role in chemical transformations, thus they 
are important for several branches of industries. 
The L-lactate dehydrogenase (LDH) from Bacillus stearothermophillus(bs) is 
substantial for the synthesis of pharmaceuticals and agrochemicals as it provides the 
production of chiral building blocks. It enables the reaction that generates hydroxy 
acids from their corresponding oxoacids. Moreover, because Bacillus 
stearothermophillus is a thermophilic bacterium, the enzyme is highly stable to heat. 
However, the enzyme has a limited substrate specificity.  
On the other hand, the enzyme is activated by an expensive activator, fructose 1,6 
bisphosphate (FBP). FBP also shows undesirable co-factor complications for 
industrial processes.  
Besides, bsLDH activity is inhibited by excess substrate (pyruvate), which is once 
more a deleterious feature owing to its industrial use. All these characteristics make 
bsLDH an applicable target for protein engineering. 
 
Previous studies have provided significant developments over these unwanted 
properties by using rational and randomized mutagenic methods. For instance, by 
Wilks et al., a Q102R substitution (found in the naturally occurring malate 
dehydrogenases) on the bsLDH sequence has been shown to convert the substrate 
specificity from lactate to malate by 3 orders of magnitude. 
 
In another research, Allen and Holbrook succeeded in producing a mutant (6A)  
which is almost fully activated in the absence of FBP. This 6A mutant had three 
amino acid replacements: R118C, Q203L and N307S, resulting in a 70-fold 
activation. Normally FBP activates the enzyme by enabling structural 
rearrangements which turns the protein into tetrameric form from dimeric form. 
Because the Q203L is located at the dimer-dimer interface, this substitution is 
thought to have realized the substrate switch by altering the dimer-tetramer 
equilibrium. 
 
By our laboratory, similar protein engineering applications have yielded significant 
effects on bsLDH as well. For example, by D38R replacement, using PCR based 
overlap extension mutagenesis, the substrate inhibition was decreased threefold by 
Binay and Karaguler. In another study, recombinant colonies, formed by random 
mutagenesis were screened and a more efficient malate dehydrogenase, compared to 
Q102R variant, was produced. 
 
Our aim in this study is forming a double mutant form of bsLDH enzyme and 
investigate its effect both on the activator need and on substrate specificity. In order 
to achieve this, Q102R and Q203L mutants were constituted by site-directed 
xviii 
 
mutagenesis in bsLDH sequence which was found in pQE2 vector. To be used in the 
PCR reaction, appropriate oligonucleotides were designed to generate Q102R and 
Q203L mutations. Following the PCR with these oligos, mutant dsDNAs were 
selected by Dpn I digestion. After that, mutated DNA was transformed into E.coli 
strain BL21 E. coli genotype fhuA2 [lon] ompT gal [dcm] ΔhsdS competent cells. 
Plasmid DNA was purified following the transformation and samples were 
sequenced to ensure to have achieved the correct mutations. According to the data 
obtained, Q102R and Q203L mutations are formed in bsLDH sequence. Mutated 
DNA was amplified in large-scale E.coli culture and the culture was precipitated in 
order to obtain protein from cells. Desired protein with 6xHis-tag was sorted from 
the protein pool by Ni-NTA resin system which selectively binds His-tagged 
proteins. Thereafter, by Sodium Dodecyl Sulphate Gel Electrophoresis (SDS-PAGE), 
the protein was visualized at the region of its molecular mass (35kDa) and have 
ensured to obtain the enzyme. By ultrafiltration, smaller proteins and other 
contaminants were removed and a purer enzyme was attained. 
With different concentrations of pyruvate as substrate, wild type and mutant enzyme 
kinetic measurements were realized in the absence and presence of FBP. Wild type 
data were found quite consistant with the previous studies. But we could not get 
detectable results in mutants with pyruvate. Actually, this phenomenon agrees with 
the Q102R mutant feature, which gives rise to a malate dehydrogenase upon 
mutation. Further experiments will be made with malate and oxaloacetate substrates 
to more precisely elucidate the double mutant effect. 
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bsLDH ENZİMİNDE Q102R VE Q203L ÇİFT MUTANTININ SUBSTRAT 
ÖZGÜLLÜĞÜ VE AKTİVATÖR GEREKSİNİMİNE ETKİLERİ 
 
ÖZET 
               
              Enzimler, organizmada meydana gelen pek çok reaksiyonun katalizini gerçekleştiren 
biyolojik aktivatörlerdir. Enzimler, girdikleri reaksiyonun yönünü değiştirmezler; 
ancak tepkimenin aktivasyon enerjisini düşürerek kimyasal dengeye gelme sürecini 
hızlandırırlar. Bu olgu, enzimlerin “aktif bölge” olarak adlandırılan kısımlarında 
substratlarıyla kompleks oluşturma özelliklerinden kaynaklanır. 
              Enzimler biyomedikal araştırmalar, ilaç sanayi ve pek çok ticari ürün eldesinde 
yaygın olara kullanılmaktadır. Günümüzde, deterjanlardan fermente içecek yapımına 
kadar pek çok uygulamada mikroorganizmalar tarafından büyük ölçekli olarak 
üretilen enzimler rol alır. 2000 yılı verilerine göre tahmini endüstriyel enzim pazarı 
değeri yaklaşık 1.5 milyar dolardır. 
              Kimyasal katalizörlerle karşılaştırıldığında yenilenebilir kaynaklardan elde 
edilmeleri, biyolojik olarak çözünebilmeleri, daha elverişli pH ve sıcaklık 
koşullarında çalışabilmeleri enzimleri çok daha tercih edilir duruma getirmiştir. Öte 
yandan artan nüfus ve azalan doğal kaynak baskısı, daha az kirlilik meydana getiren 
üretim yöntemlerini tercih etme gerekliliğini ortaya koymuştur.  
              Klasik kimyasal katalizörlere karşı üstünlükleri, enzimleri giderek daha önemli 
endüstriyel ürünler haline getirse de, çoğu enzim ticari uygulamalar açısından gerekli 
özellikleri barındırmaz. İstenen koşullarda, daha yüksek verimle, daha fazla substrat 
kullanarak çalışabilen enzimler üretmek protein mühendisliği uygulamalarıyla 
mümkün hale gelmiştir. Bu uygulamalarda rasyonel dizayn ve yönlendirilmiş evrim 
olmak üzere iki ana yöntem ile bu ikisinin olumlu özellikleri alınarak elde edilmiş 
yarı-rasyonel dizayn sistemi kullanılmaktadır. Rasyonel dizayn, bilgisayar programlı 
modelleme ve biyoinformatik bilgisi ışığında proteinin yapısal ve işlevsel 
özelliklerini ortaya koyma ve buradan hareketle hedeflenen bölgelerde mutasyon 
yapma esasına dayanır. Yönlendirilmiş evrim ise doğal bir süreç olan evrim 
mekanizmasını laboratuvar ortamında ve moleküler seviyede taklit eder. Bu 
yöntemde, ilgili protein dizisi üzerinde rastgele mutasyonlar oluşturulur, daha sonra 
mutant bireyler, proteinin değiştirilmek istenen karakterini taşıyıp taşımamalarına 
göre ayırt edilir. Yarı-rasyonel dizayn ise bir yandan rasyonel dizayndaki yapı ve 
fonksiyon bilgisi gerekliliğini, diğer yandan yönlendirilmiş evrimdeki çok sayıda 
birey tarama zorluğunu ortadan kaldırır. 
              Laktat dehidrogenaz (LDH) enzimi, glikolizin son adımında piruvatı laktata 
dönüştüren enzimdir. NAD-bağımlı 2-hidroksikarboksilat dehidrogenazlar ailesinin 
üyesidir. Piruvatın laktata çevrilmesi reaksiyonunu terisinir olarak katalizlerken 
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kofaktörü olan NADH’yi de NAD+’a yükseltger. Hemen her organizmadan izole 
edilen LDH, oksijenli ve oksijensiz solunum yolaklarında kullanılabilen bir ara ürün 
olan piruvatı üretimi/tüketimi bakımından önemlidir. Prokaryotik ve ökaryotik olmak 
üzere, bilinen iki tip LDH vardır.  
               
              Bacillus stearothermophillus bakterisinden elde edilen L-laktat dehidrogenaz enzimi 
(bsLDH), eczacılık ve zirai kimyasallarda kullanılmak üzere kiral yapıtaşları elde 
etme işleminde ticari yönden oldukça önemlidir. Her ne kadar yüksek stereo 
uygunluk seviyesiyle kiral hidroksiasitlerin sentezine olanak sağlasa da, bsLDH dar 
substrat özgüllüğüyle endüstriyel üretim açısından dezavantaj oluşturmaktadır. 
Termofil bir bakteriden elde edilen ve bu yüzden ısıya karşı oldukça stabil olan bu 
enzim substrat kullanımını artırmak için oldukça uygun bir hedeftir. 
              Öte yandan, bsLDH enzimi fruktoz 1,6 bisfosfat (FBP) tarafından aktive 
edilmektedir. Aktivasyon, dimerik formda düşük substrat afinitesi gösteren enzimin, 
FBP bağlanmasıyla çok daha aktif olan tetramerik forma geçmesiyle gerçekleşir. Bu 
aktivatör pahalı olmakla beraber, endüstriyel süreçte istenmeyen ko-faktör 
problemlerine yol açar. Protein mühendisliği yöntemleriyle, enzimin aktivatör 
kullanımını azaltmak hedeflenmektedir. 
               
Günümüze kadar yapılan çalışmalar, rasyonel ve randomize mutajenik metotlar 
kullanarak, enzimin substratlarının artırılmasında ve özgüllüğünün değiştirilmesinde 
önemli yol kat etmeyi sağlamıştır. Örneğin, Wilks ve arkadaşları, bsLDH dizisinde 
Q102R mutasyonuyla, substrat kullanımını laktat-piruvat çiftinden oksaloasetat-
malat çiftine dönüştürmeyi, yani LDH gen dizisinde değişiklik yaparak malat 
dehidrogenaz işlevi gören bir enzim tasarlamayı başarmıştır.  
 
              Başka bir çalışmada Allen ve arkadaşları, üç dizi randomize mutagenez ve tarama 
yöntemiyle FBP yokluğunda da aktif, üç amino asit mutasyonu taşıyan (R118C, 
Q203L, N307S) 6A mutantı üretmiştir. Mutantın sözü edilen aktivasyon özelliğini 
göstermesinde etkili bölge olarak dimer-dimer arayüzünde bulunan Q203L 
mutasyonu gösterilmektedir. Yabanıl tip bsLDH için FBP varlığında KMpyr 5mM 
iken, FBP ile aktive edildiğinde KMpyr 0.05 mM’a düşer. 6A mutantında ise FBP 
yokluğunda KMpyr 0.07 dir. Bu da FBP’li yabanıl tip değerine oldukça yakındır. 
 
              Bu çalışmada amaçlanan, bsLDH enziminin, sözü edilen Q102R ve Q203L 
mutantlarını aynı dizide oluşturarak çift mutant elde etmek ve bunun FBP 
gereksiniminin yanı sıra substrat özgünlüğünü araştırmaktır. Bunu gerçekleştirmek 
için, pQE-2 klonlama vektörü içinde bulunan bsLDH gen dizisinde, bölgeye özel 
mutagenez sistemi kullanılarak Q102R ve Q203L mutasyonları oluşturulmuştur. 
Öncelikle Polimeraz Zincir Reaksiyonunda (PZR) kullanılmak üzere uygun 
oligonükleotitler tasarlanmıştır. PZR’yi takiben, mutant çift sarmal DNA’ların seçimi 
Dpn I yıkımıyla gerçekleştirilmiştir. Sonrasında BL21 kompetent E. coli genotip 
fhuA2 [lon] ompT gal [dcm] ΔhsdS hücrelerinde transformasyon yapılmış ve plazmit 
DNA’sı saflaştırılmıştır. Örnekler dizilemeye tabi tutulmuş ve doğru mutantların elde 
edildiği, yabanıl tip dizi ile mutant dizi karşılaştırılarak teyit edilmiştir. Elde edilen 
veriye göre bsLDH dizisinde Q102R ve Q203L mutasyonları gerçekleşmiştir. Mutant 
diziye sahip DNA, E. coli hücrelerinde çoğaltılmış, besi yerleri çöktürülerek protein 
izolasyonu için hücre eldesi sağlanmıştır. 6-His-tag’le işaretlenen LDH proteini, bu 
diziyi seçici olarak tanıyan ve ortamdan izole edilmesini sağlayan Ni-NTA agaroz ile 
ayrıştırılmıştır. Sodyum dodesil sülfat – poliakrilamid jel elektroforeziyle (SDS-
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PAGE) kendi moleküler ağırlığına karşılık gelen bölgede görüntülenerek proteinin 
elde edildiği doğrulanmıştır. Ardından, ultrafiltrasyon yöntemiyle LDH dışındaki 
tüm proteinler ortamdan uzaklaştırılmış, daha saf bir enzim eldesi sağlanmıştır. 
              Yabanıl tip ve mutant enzimlerin kinetik ölçümleri FBP varlığında ve yokluğunda 
substrat olarak değişen konsantrasyonlarda piruvat kullanılarak gerçekleştirilmiştir. 
Bunun sonucunda yabanıl tip LDH kinetik ölçümleri FBP varlığında, literatürdekine 
çok yakın değerler vermiştir. Öte yandan, mutant enzimin piruvat ile kinetik 
ölçümlerinden saptanabilir bir veri elde edilememiştir. Bu durum, Q102R mutasyonu 
ile malat dehidrogenaz işlevi gösteren enzim oluşturulması durumuyla örtüşmekte ve 
yapılan mutasyonun doğru çalıştığına işaret etmektedir. Benzer kinetik deneyler, 
malat ve oksaloasetat substratları ile tekrar edilecek, çift mutant etkisi daha kesin 
şekilde aydınlatılacaktır. 
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1. INTRODUCTION 
1.1.  Lactate Dehydrogenase 
Lactate dehydrogenases (LDHs) belong to a wide group of 2-ketoacid : NADP-
dependent dehydrogenases. They catalyze the interconversion of 2-hydroxyacids 
(pyruvate) to the corresponding 2-ketoacids (L-lactate) (Holbrook et al., 1975) and 
meanwhile NADH is used as a coenzyme as shown in Figure 1.1. LDH is one of the 
most extensively studied enzymes and plays role in the last step of anaerobic 
glycolysis. Many LDHs have been isolated and characterized from a variety of 
organisms. Its catalytic mechanism has been described in detail. It includes 
conformational rearrangements of the structure upon substrate binding and release 
(Gerstein, M. & Chothia, C., 1991). When the competent catalytic state is reached, 
the enzyme catalyzes the direct transfer of a hydride ion from the pro-R face of 
NADH to the C2 carbon of pyruvate (Burgner & Ray, 1984; Deng et al., 1994).  
 
Figure 1.1: The reaction catalysed by NAD+-dependent lactate dehyrogenases. 
There are 2 types of LDHs identified so far: the prokaryotic-type and the eukaryotic-
type enzymes. Although the latter is studied more in detail, they are structurally 
related. While vertebrate LDHs do not need to be activated by an allosteric effector 
(non-allosteric enzyme), some prokaryotic LDHs are activated by fructose-1,6-
bisphosphate (FBP) molecule. The Bacillus stearothermophilus LDH (bsLDH) is a 
typical prokaryotic type enzyme, sequence of which is shown in Figure 1.2. 
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Figure 1.2: Domains of bsLDH. 
Interconversion of pyruvate and lactate by LDH is realized in different tissues by 
isozymic forms of the enzyme. LDH is composed of a tetramer of two kinds of 35-kd 
subunits encoded by similar genes. In 1964, the first X-ray diffraction results for M4 
isozyme for pig were declared. After then, the enzyme was isolated from many 
species as well. The family of these isozymes is composed of the two isozymic 
polypeptide chains for this enzyme: the H isozyme highly expressed in heart and the 
M isozyme found in skeletal muscle ( Fine et al., 1963). The amino acid sequences 
are 75% identical. These subunits combine to form the tetramers: H4, H3M1, H2M2, 
H1M3, and M4. The H4 isozyme (type 1) has higher affinity for substrates than does 
the M4 isozyme (type 5) and, unlike M4, is allosterically inhibited by high levels of 
pyruvate. The other isozymes have intermediate properties, depending on the ratio of 
the two kinds of chains. H4 is  designed to oxidize lactate to pyruvate, which is then 
utilized as a fuel by the heart through aerobic metabolism. Indeed, heart muscle 
never functions anaerobically. In contrast, M4 is optimized to operate in the reverse 
direction, to convert pyruvate into lactate to allow glycolysis to proceed under 
anaerobic conditions (Berg et al., 2002, pp 421-422). A third homotetramer of X-
subunits is only present in adult male testicular tissue. Isozymes and isozyme profile 
changes are shown in Figure 1.3. 
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Figure 1.3: Isozymes of lactate dehydrogenase. (A) The rat heart LDH isozyme  
           profile changes in the course of development. The H isozyme is  
                represented by squares and the M isozyme by circles. The negative         
    and positive numbers denote the days before and after birth,  
                             respectively. (B) LDH isozyme content varies by tissue (Berg et al., 
                             2002, p.422). 
 
The appearance of some isozymes in the blood is indicative of tissue damage and can 
be used for clinical diagnosis. For instance, an increase in serum levels of H4 relative 
to H3M is an indication that a myocardial infarction, or heart attack, has occurred. 
The structures of the ternary complexes of LDH were deduced from crystallographic 
studies of the binding of NAD-pyruvate. bsLDH was crystalised and the three 
dimensional crystal structures of the enzyme were solved in the apo and holo forms 
(Birktoft et al., 1982). 
1.2. NAD-Binding of Dehydrogenases 
Glyceraldehyde 3-phosphate dehydrogenase, alcohol dehydrogenase, and lactate 
dehydrogenase have in common a domain for NAD+ binding, demonstrated in Figure 
1.4. This nucleotide-binding region is made up of four α helices and a sheet of six 
parallel β strands. This common structural domain, is called a Rossmann fold after 
Michael Rossmann, who first recognized it. This fold represents an aboriginal 
dinucleotide-binding domain that is found in the dehydrogenases of glycolysis and 
other enzymes indicating their descent from a common ancestor (Berg et al., 2002, p. 
655). 
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Figure 1.4: NAD+ binding region in dehydrogenases (Berg et al., 2002, p.666) 
1.2.1 NADH binding of LDH 
Nicotinamide adenine dinucleotide (NADH) is a coenzyme composed of 
ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by 
pyrophosphate linkage. It is involved in numerous enzymatic reactions in which it 
serves as an electron carrier by being alternately oxidized (NAD+) and reduced 
(NADH). These forms are shown in Figure 1.5. 
 
 
Figure 1.5: Structure of NAD+ and NADH. 
Directed by the rotation of glycosidic bond, the nicotinamide ring can be positioned 
in two orientations ( Arnott and Hukins, 1972, p.453). It is adjusted due to the 
display of the A and B-side of the ring to the substrate site.  
According to the quantum chemistry calculations, the binding mechanism involves 
the donation of a hydride ion H-, from the C2 carbon of lactate to the pro-R, re face 
of the nicotinamide moiety of the coenzyme combined with the transfer of a proton   
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from the O3 oxygen of lactate to the active-site histidine His-195 (Wilkie and 
Williams, 1992; Andres et al., 1993).  
The interaction mechanism between the coenzyme and the protein remained unclear 
for a while. Previously, it was believed that the hydroxyl of Ser-163 residue 
(conserved in all known LDH sequences) made hydrogen bonding with the nitrogen 
atom of the carboxyamide side-chain of the coenzyme. Later on, this amino acid 
residue was found to be unsignificant for the binding ( Wigley et al., 1987). On the 
other hand, researches highly support the presence of the hydrogen bonding  between 
the carboxamide side chain of NADH and the enzyme. In such a study, it was found 
that NADH affinity of the LDH is more than its affinity for 3-acetyl pyridine, an 
anolog of NADH (Fine et al., 1963, p.116). Latter studies have suggested that it is 
very likely there is a hydrogen bond between the nitrogen atom and the main-chain 
carboxyl group of residue 138. Residues important in binding are indicated in Figure 
1.6. 
 
 
 
Figure 1.6: Binding residues in bsLDH sequence. Two stereo views comparing 
                    the wild-type-bsLDH structure complexed with either pyruvate (thin  
   lines) or phenylpyruvate (thick lines). (El Hawrani, 1996). 
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1.3 Active Site of the Enzyme 
The active site of an enzyme is the region that binds the substrate and contributes the 
amino acid residues that directly participate in the making and breaking of chemical 
bonds. 
Sequences and conformations of LDHs are different in spite of the same substrate, as 
they are derived from different sources. Residues 98 to 110 consists of the active site 
in bsLDH and the conformation of this loop determines substrate.  
1.3.1 Substrate (pyruvate) binding of LDH 
Pyruvate is the anion of pyruvic acid. It is a crucially important compound as it is the 
end product of glycolysis. The structure of pyruvate is shown in Figure 1.7. Pyruvate 
stands at the junction between aerobic and anaerobic pathways. In anaerobic 
respiration, pyruvate is used as the starting point for fermentation, yielding either 
ethanol or lactate. For aerobic respiration, pyruvate is transported to 
the mitochondria to be used in the TCA cycle. 
 
Figure 1.7: Structure of pyruvate. 
In the LDH: NAD-pyruvate ternary complex, the position of the substrate binding 
site has been determined by the pyruvate.  
Thr-246 seems to be an important residue for bsLDH. It is found in all LDHs. In a 
mutant enzyme study, the role of this residue for substrate binding was revealed. By 
the replacement of Thr-246 by glycine, a malate dehydrogenase could be designed 
(Wilks et al., 1988).  
A salt bridge is formed between the carboxylate of the substrate and the side chain of 
Arg-171. The imidazole ring of the His-195 generates a hydrogen bond with the 
carbonyl group. While His-195 orients pyruvate, it also stabilizes the negative charge 
of the substrate formed during reduction (Clarke et al., 1988). 
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In addition, when NAD+ is bound, Asn-140 becomes accessible for hydrogen 
bonding to the carbonyl of pyruvate. When reduced, however, NAD+ coenzyme loses 
its charge and this charge is transferred to His-195 ( Hart et al., 1987).  
Here, His-195 behaves like a redox enzyme to realize the reaction. 
Site-directed mutagenesis studies of the LDH active site have shown that Arg-109 
(Clarke et al., 1986) and Asp-168 are substantial in the rate enhancement produced by the 
enzyme. Arg-109 causes a polarization of the carbonyl bond of the oxidized 
substrate, pyruvate (Clarke et al., 1986; Deng et al., 1994). Asp-168 is responsible for 
modulating the pKa of His-195 (Clarke et al., 1988). Likewise studies have revealed 
that Arg-171 is a vital residue in correctly binding the substrate carboxylate to the 
enzyme. (Hart et al., 1987).   
LDH:NAD-pyruvate ternary complex is isomorphous with respect to the 
LDH:NAD:oxalate and further form the coenzyme than the pyruvate. 
1.4 The Activator (Fru-1,6-P2) Binding of LDH 
Fructose 1,6-bisphosphate (FBP), also known as Harden-Young ester, is fructose 
sugar phosphorylated on carbons 1 and 6, as shown in Figure 1.8. The β-D-form of 
this compound is abundantly found in cells. The vast majority of glucose and 
fructose entering a cell is converted to fructose 1,6-bisphosphate. Fructose 1,6-
bisphosphate plays role in the glycolysis metabolic pathway and is produced by 
phosphorylation of fructose 6-phosphate. It is, in turn, broken into two 
compounds: glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. It is 
an allosteric activator of pyruvate kinase. 
It has been shown that two FBPs bind per bs LDH. In many bacteria (e.g., Thermus, 
Lactobacili, Bacili) LDH activity is markedly regulated by FBP (Clarke et al., 1986).   
 
 
Figure 1.8: Structure of fructose-1,6-bisphosphate (url-1). 
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bsLDH is allosterically activated by FBP. This activation is formed by the FBP 
induced tetramerization of the dimeric enzyme. Upon this reaction, a structural 
rearrangement of key active site residues is realized and the enzyme becomes 
activated (Clarke et al., 1987). The non-activated form has a Km for pyruvate of 5 
mM. However, in the presence of FBP, the Km for pyruvate drops to 0.05 mM. 
 
In fact, dimeric form of the enzyme shows substrate affinity to a certain extent. But, 
the liganded tetramer and to a lesser extent the unligated tetramer have high affinity.  
The two FBP molecules are located in a central hole in the enzyme and connect to 
the P-axis with their phosphate groups. This conformation stabilizes the assembled 
tetramer. In the absence of activator, the subunit interface on the P-axis is less  stable 
; the protein  segregates and give dimers . These subunits are united by the Q axis 
which is stable.  Along the 163-195 residues, both the substrate and the activator 
binding (anion group) sites are located. The binding of the FBP anion site to the His-
188 and Arg-173 leads to a change in the relative His-195 and  Arg-171, which in 
turn bridges the βG/βH-2αF structure. While  the enzyme catalyzes the reaction, 195 
and 171 residues hold carbonyl and carboxylate groups of pyruvate (Holbrook et al., 
1975). From this point, we can  conclude that their orientation must be important to 
regulate the firmness of the substrate binding. 
1.5 Enzyme Kinetics 
Living systems depend on chemical reactions which, on their own, would occur at 
extremely slow rates. Enzymes are catalysts which reduce the needed activation 
energy so these reactions proceed at rates that are suitable for the cell. 
For many enzymes, the rate of catalysis V 0, which is defined as the number of moles 
of product formed per second, depends on the substrate concentration [S]. The rate of 
catalysis goes up linearly as substrate concentration increases. When reached a 
maximum, it no more rises with higher substrate concentrations and begins to fall.  
The Michaelis-Menten model complies with the kinetic features of many enzymes. 
The rate V 0 of formation of product is given by the Michaelis-Menten equation: 
 
                                                       (1.1)                   
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Here, V max is the reaction rate when the enzyme is fully saturated with substrate 
and K M (Michaelis constant), is the substrate concentration at which the reaction rate 
is half of the maximal rate. The maximal rate, V max, is equal to the product of 
k2 or k cat and the total concentration of enzyme. The kinetic constant k cat, called the 
turnover number, is the number of substrate molecules converted into product per 
unit time at a single catalytic site when the enzyme is fully saturated with substrate. 
Turnover numbers for most enzymes are between 1 and 104 per second. The ratio of 
k cat/K M provides a penetrating probe into enzyme efficiency. In Figure 1.9, 
Michaelis-Menten graph is indicated. 
 
 
Figure 1.9: Michaelis-Menten kinetics. 
A plot of 1/V 0 versus 1/[S], called a Lineweaver-Burk or double-reciprocal plot, 
yields a straight line with an intercept of 1/V max and a slope of K M/V max, as 
shown Figure 1.10. The intercept on the x-axis is -1/K M. 
 
 
Figure 1.10:  Lineweaver-Burk plot.  
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1.5.1 Kinetic mechanism of LDH 
The kinetic mechanism of LDH is evaluated as ordered; because unless the 
coenzyme is bound to enzyme, lactate or pyruvate can not bind (Clarke & Daffron, 
1998). Crystallographic studies show that coenzyme binding leads to a 
conformational change which moves 98-110 residues to close up the active site 
(Adams, 1968; White, 1976).  
At neutral pH, lactate and NAD+ is preferred by the reaction equilibrium. While 
pyruvate dissociates, the equilibrium is shifted through the products and all bound 
NAD+ molecules become reduced. The rate-limiting step starts with the slower 
dissociation of NADH, in the steady state (Figure 1.10). As mentioned before, 
binding of the activator FBP stabilizes the tetrameric form and in this manner, the 
enzyme binds pyruvate 50 times more strongly than the dimeric structure does. In 
addition, NAD+ regeneration is induced by the formation of the glycolytic 
intermediate Fru-1,6-P2 (Bizzari and Kishi, 2003). The kinetic mechanism of bsLDH 
is indicated in Figure 1.11. 
 
Figure 1.11: Kinetic mechanism of bsLDH 
1.6 Substrate Inhibition of LDH 
It  has been shown that mammalian and bacterial dehydrogenases are inhibited by 
high concentrations of pyruvate during the enzyme catalysis. This   is due to the 
formation of a covalent abortive adduct . The adduct is formed between pyruvate and 
NAD+, just before the release of oxidized cofactor  (NAD+) (Fromm, 1961; 
Gutfreund et al., 1968; Coulson & Rabin, 1969).  The adduct binds tightly to the 
enzyme meanwhile it is produced by the naturally occuring reaction, and in turn  it 
inhibits the further redox catalysis ( Everse et al., 1971).  
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By previous studies, it   has been demonstrated that this substrate inhibition can be 
removed by S163L  mutation in Bacillus stearothermophilus and human muscle 
LDHs (Eszes et al., 1996; Hewitt et al., 1997). Later, it is also shown that the same 
mutation is effective in human heart isoform, the most strongly substrate-inhibited 
LDH known (Hewitt et al., 1999). 
Binay and Karaguler (2007), also showed that the substrate inhibition of bsLDH is 
decreased three-fold by substituting the conserved aspartic acid residue at position 38 
by arginine. This is due to the weakining of NAD+ binding of the enzyme; longer 
basic arginine residue instead of aspartic acid changes the binding properties of the 
coenzyme and thus decreases the formation of the abortive NAD+-pyruvate complex. 
1.7 Industrial Importance of LDH 
For the “greening” of chemical manifacture, biocatalytic applications are being more 
and more attractive ( Allen and Holbrook, 2000). 
The reaction catalyzed by LDH- interconversion of pyruvate (oxo acid) and lactate 
(hydroxy acid) is important in various sections of industry. For producing several 
pharmaceuticals such as semi-synthetic penicillin (from S-α-hydroxyisocaproic acid) 
and antihypertensives (from S-α-hydroxyl-4-phenyl butanoate), obtaining chirally 
pure α-hydroxy acids from their corresponding achiral α-oxo acids is of great value. 
They are used in medicine as well, to diagnose phenylketonuria by detecting S-
ketoisohexanoic acid (Karaguler et al., 2007).  
One important α-hydroxy acid is lactic acid that is produced by bsLDH. Lactic acid 
is a colorless liquid organic acid and is miscible with water or ethanol. It exists as a 
racemate mixture, made up of stereoisomers. Global lactic acid production is 
estimated to be more than 100,000 tons per year and approximately 75% of the lactic 
acid produced is used in the food industry as an acidulant for flavor or as an 
antimicrobial agent (Raber, 1998). More recent uses for lactic acid have been for 
ecological interest and involve the nonchlorinated solvent ethyl lactate and the 
biodegradable plastic polylactic acid production ( Skory, 2000). 
On the other hand, working with thermostable enzymes has advantages over the non-
thermostables. They are robust, have good stability and are relatively tolerant to 
organic solvents. Reactions can be run at higher temperatures thus minimizes the risk 
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of microbial contamination, eases solubility and viscosity (Allen and Holbrook, 
2000). Together with other dehydrogenases, LDH shows significant promise for 
industry as it may constitute a key step in various synthesis works.  
1.8 Protein Engineering 
Many microorganisms produce several enzymes naturally. However, to use these 
natural enzymes in industry has some limitations such as low catalytic efficiency, 
low activity and low stability. In order to overcome these limitations, many protein 
engineering applications have been developed. These applications rely on two main 
strategies: rational design and directed evolution. Rational design is the earliest 
approach. It requires information of the structural properties of the enzyme active site 
and its role in the functioning of the protein. More recently, directed evolution has 
become a popular tool, as it allows relatively rapid engineering of enzymes without 
requiring detailed information about structure-function relationship, unlike rational 
design (Chica et al., 2005). Finally, semi-rational approach has got on the stage and 
proven to be especially advantageous as it has the virtues of both strategies. It does 
not need high-throughput screening method and a smarter library can be formed in 
comparison to the random whole-gene mutagenesis approach (Dalby, 2003). 
Some new methods have been developped that stand between the directed and 
rational approaches. These techniques are summarized in Figure 1.12. Also, 
advantages and disadvantages of mentioned techniques are stated in Table 1.1. 
1.8.1 Directed evolution 
Directed evolution is a sweeping term that includes a variety of methods for 
improving or changing the function of enzymes using a nature-inspired twofold 
strategy of mutagenesis followed by selection. Through a user-defined aim, it mimics 
the natural selection process in order to produce more efficient nucleic acids or 
proteins, as indicated Figure 1.13. It is widely accepted as the most effective and 
useful application in modifying enzymes, especially to increase catalytic 
performance (Hida et al., 2007). 
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Figure 1.12: Molecular engineering methods and procedures to improve the 
         performance of industrial enzymes (Yang et al., 2014). 
 
Figure 1.13: An overview of directed evolution. 
1.8.2 Rational design 
The first approach in this stage, rational design relies on the basis of predicting how 
an alteration in the structure of a molecule will affect its function. It gets line on 
computational programs which enable scientists to make complex modelling and 
calculations about a molecule’s framework. Thus, unlike directed evolution, in this 
approach, having knowledge about the conformation and proceeding on the 
assumption of how it would likely to change its behaviour are indispensible. 
Site directed mutagenesis : It is a rational design application which entails 
producing single and combinational mutations in order to modify enzyme genes. It is 
based on analyses of the structure, function, catalytic mechanism, and catalytic 
residues of enzymes.  
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This method is especially utile when a specific residue of a protein is important in the 
structure or function. This could be realized, for instance, removing the target amino 
acid completely or substituting it with a different residue. Alanine (alanine scanning) 
is frequently used for this purpose as its side chain is non-bulky, non-charged, 
chemically unreactive and is compatible with several structural motif formantion. 
This type of engineering can be accepted “blind” via transposition of all backbone 
residues, or can be more targeted  (e.g. the replacement of a specific amino acid 
believed to be within an enzyme’s active site in order to map the active site more 
efficiently). 
Table 1.1: Advantages and disadvantages of different molecular engineering 
                              methods (Yang et al., 2014) 
Factors Advantages Disadvantages 
Directed Evolution Mimic natural evolution Random mutation library is 
large; low efficiency 
Site-directed mutagenesis Directed; high efficiency; 
mutation library is small; 
simplify methods for 
mutagenesis 
The structure-function 
relationship of the target 
enzyme should be clear 
Saturation mutagenesis Easy; the screening effort 
drastically 
Mutation library is large 
Iterative saturation  
mutagenesis 
High-quality libraries; more 
efficient and faster than 
others (e.g. saturation mut.) 
Mutation library is large 
Truncation High efficiency The relationships between 
domains and properties 
should be clear 
Fusion The structure-function 
relationship of the target 
enzyme is not necessary 
There is not a clear 
criterion of the fusion 
sequence 
1.8.3 Semi-rational design 
Semi-rational design can be defined as a combination of random methods of directed 
evolution and the virtues of rational enzyme adjustment. Thus, the limitations of both 
directed evolution and rational design can be overcome. By this method, “smart” 
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libraries (similar to directed evolution) that are more likely to render positive results 
can be formed as it is already targeted to particular residues which are determined 
prior to mutation by use of structural and functional knowledge (similar to rational 
design) (Chica et al., 2005). 
Site-saturation mutagenesis: Site-directed saturation mutagenesis is used to quickly 
evolve the protein in laboratory conditions. In this system, each amino acid of a 
protein is exchanged with each of the other 19 naturally occuring amino acids. 
“Hotspots” of enzymes are the targets for saturation mutagenesis and enhanced 
thermostability or catalytic efficiency can be obtained by variants with single amino 
acid changes (Chen et al. 2012). A special form of this method is named as “iterative 
saturation mutagenesis” (ISM). It involves  
- Randomized mutation of proper sites of residues 
- Screening of the initial mutant libraries for properties such as catalytic 
efficiency, stereoselectivity, and thermal robustness 
- Use of the best individual in a library as a template for saturation mutagenesis 
at other sites 
- Continuation of the process until the desired degree of enzyme improvement 
has been reached (Gumulya et al. 2012). 
Truncation: As some domains of proteins are not essential for enzyme activity, 
truncation can be used to enhance or change the properties of enzymes. This may be 
realized by random or directed truncation. In random mutation, mutants with desired 
properties are screened through a truncation library. On the other hand, by means of 
site-directed truncation, truncated enzymes can be directly obtained (Yang et al., 
2014). 
Fusion: Latterly, the building of new chimeric enzymes has become a novel and 
important phenomenon for enzyme engineering, especially to improve the catalytic 
quality. By fusing the catalytic and substrate binding domains of different enzymes, 
most chimeric proteins are obtained. Carbohydrate-active enzymes, for example, are 
good targets for fusion strategy. They contain two distinct modules, a catalytic 
module and a carbohydrate-binding module (CBM), that are discrete structural and 
functional units usually connected by a flexible linker. There are 54 defined families 
of CBMs based on amino acid similarities (Han et al.2013; Linke et al. 2012), and 
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these CBMs display significant diversity in ligand specificity. Therefore, different CBMs 
usually interact with different carbohydrates. Therefore, CBMs are usually fused with other 
enzymes to create new chimeric enzymes to improve catalytic quality. 
A chart about how to choose the right strategy to engineer a protein is given in Figure 1.14. 
 
 
Figure 1.14: Selection of the preferred experimental approach for enzyme  
                                 engineering based on the availability of tools and prior  
                                 knowledge of structure and function. 
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2.  MATERIALS & METHODS 
2.1. Materials  
2.1.1. Laboratory equipment 
Equipments used are given in Table 2.1. 
 
Table 2.1: Equipments used in the study. 
 
Equipment  Supplier company 
Centrifuge Beckman Coulter Microfuge®18, Beckman 
Coulter Allegra 25R, Beckman Coulter J-30 I 
 
High pressure steam sterilizer TOMY SX-700E 
Tuttnauer Systec 2540 mL 
Magnetic stirrer Heidolph MR Hei-Standard 
pH meter Hanna Instruments HI 221 Microprocessor pH 
meter 
Precision scale Precisa XB 220 A 
Precisa BJ 610 C 
Power supply Biometra PowerPack P25T 
Vortex Heidolph  
Ice machine Scotsman AF 10  
Microwave Oven White Westinghouse MicroMagic 
Thermal cycler Biometra Professional 
Shaker  Heidolph Duomax 1030 
Freezers  SANYO Biomedical Freezer (-20oC), 
Electrolux SpacePlus (+4 oC), New 
Brunswick Scientific (-80 oC)  
Spectrophotometer Shimadzu UV 1601 UV visible 
spectrophotometer 
Microplate Spectrophotometer BioRad Benchmark Plus 
Microfuge tubes 1.5ml, 2ml, Axygen  
Centrifuge tubes 15ml, 50ml ISOLAB 
Micropipettes  2.5μl, 10μl, 100μl, 200μl, Eppendorf 1000μl, 
Finnpipette Thermo  
Spectrophotometer cuvettes Plastibrand 1.5 mL semi-micro 
Pure water system TKA Wasseraufbereitungssysteme  
Electrophoresis equipment Whatman, Inc. Horizon 20-25  
Thermoshaker Biometra 
Incubator GFL 
  Centrifugal ultrafiltration tube   Milipore  
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2.1.2. Chemicals 
Chemicals used are listed in Table 2.2. 
 
Table 2.2: Chemicals used in the study. 
 
2.2.  Methods  
2.2.1. Cloning studies 
In this study, pQE2 vector is used as cloning vector. In Figure 2.1, vector map of 
pQE2 is shown. This vector is 4800 bp. long. 
 
Figure 2.1: pQE-2 vector map
Chemical Supplier company 
Sodium chloride (for analysis) Merck 
Yeast extract powder Lab M Limited 
Agar Bacteriological Oxoid 
Pepton from casein Merck 
Potassium chloride GPRTM BDH Laboratory supplies 
Sodium pyruvate Fluka 
Ammonium persulfate for electrophoresis Sigma 
Tris (Hydroxymethyl)- aminomethan Merck 
EDTA (Ethylenediaminetetra-acetic acid 
Disodium salt) 
GPRTM BDH Laboratory supplies 
Unstained protein marker Fermentas SM0431 
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High-level expression of 6xHis-tagged proteins in E. coli using pQE vectors is based 
on the T5 promoter transcription–translation system. pQE plasmids belong to the 
pDS family of plasmids and were derived from plasmids pDS56/RBSII and 
pDS781/RBSII-DHFRS (Bujard et al., 1987). These low-copy plasmids have the 
following features:  
• Optimized promoter–operator element consisting of phage T5 promoter (recognized 
by the E. coli RNA polymerase) and two lac operator sequences which increase lac 
repressor binding and ensure efficient repression of the powerful T5 promoter 
• Synthetic ribosomal binding site, RBSII, for high translation rates • 6xHis-tag 
coding sequence either 5' or 3' to the cloning region  
• Multiple cloning site and translational stop codons in all reading frames for 
convenient preparation of expression constructs  
• Two strong transcriptional terminators: t0 from phage lambda, and T1 from the 
rrnB operon of E. coli, to prevent read-through transcription and ensure stability of 
the expression construct 
• β-lactamase gene (bla) conferring resistance to ampicillin at 100 µg/ml. The 
chloramphenicol acetyl transferase gene (CAT) present between t0 and T1 has no 
promoter and is not normally expressed. Depending on the bacterial strain and insert, 
low CAT activities may be detectable.  
• ColE1 origin of replication. 
2.2.2. Primer design 
Primer design is accomplished by applying the instructions recommended in the 
QuikChange® II XL Site-Directed Mutagenesis Kit. According to this kit, primers 
are prepared by the following considerations: 
• Both mutagenic primers must contain the desired mutation and anneal to the same 
sequence on opposite strands of the plasmid. 
• Primers should be between 25 and 45 bases in length, with a melting temperature 
(Tm) of ≥75°C. Primers longer than 45 bases may be used, but using longer primers 
increases the likelihood of secondary structure formation, which may affect the 
efficiency of the mutagenesis reaction. 
The following formula is commonly used for estimating the Tm of primers: 
            Tm = 81.5 + 0.41(%GC) - 675/N - % mismatch                                  (2.1)                     
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For calculating Tm: 
• N is the primer length in bases. 
• values for %GC and % mismatch are whole numbers. 
For calculating Tm for primers intended to introduce insertions or deletions, use this 
modified version of the above formula: 
Tm =  81.5 + 0.41(%GC) - 675/N                                        (2.2) 
where N does not include the bases which are being inserted or deleted. 
• The desired mutation (deletion or insertion) should be in the middle of the primer 
with ~10–15 bases of correct sequence on both sides. 
• The primers optimally should have a minimum GC content of 40% and should 
terminate in one or more C or G bases. 
Applying these recommendations, the following primers are designed by the 
help of OligoEvaluator™  Sigma-Aldrich system. 
• Sequence (5’-3’): CGG TCT GGA GCC AGG CTT ATA TCG GCG 
F Primer: CGG TCT GGA GCC TGG CTT ATA TCG GCG 
R primer: GCC AGA CCT CGG ACC GAA TAT AGC CGC
Analysis result of this primer pair is given in Figure 2.2. 
 
 
Figure 2.2: Analysis result of the Tm 78.9 primer pair. 
• Sequence (5’-3’): CCC GGT CTG GAG CCA GGC TTA TAT CGG CG 
F primer:  CCC GGT CTG GAG CCT GGC TTA TAT CGG CG   
R primer: GGG CCA GAC CTC GGA CCG AAT ATA GCC GC 
Analysis result of this primer pair is given in Figure 2.3. 
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Figure 2.3: Analysis result of the Tm 82.1 primer pair. 
2.2.3. Polymerase chain reaction (PCR) 
PCR is a method which enables the synthesis of new DNA strand complementary to 
the related template strand. It uses the enzyme DNA polymerase which has the 
ability to add nucleotides to  3'-OH group of the DNA. Thus, a primer is required to 
which add the first nucleotide. This situation also allows to select a particular region 
to amplify. As a consequence of PCR, a large number of copies of the desired 
sequence is produced. 
In order to introduce the desired mutation to the bsLDH gene in pQE vector, the PCR 
reaction shown in Table 2.3. is set. 
 
               Table 2.3: PCR reaction for bsLDH  Q203L mutation. 
Content Volume 
Plasmid DNA template (119,9 ng/µl) 0,4 µl 
Forward primer (10µM) 1 µl 
Reverse primer (10µM) 1 µl 
dNTP mix 1 µl 
Quick solution mix 3 µl 
Pfu polymerase 1 µl 
10x reaction buffer 5 µl 
ddH20 37,6 µl 
Total reaction volume 50 µl 
 
To ensure that the PCR reaction is accomplished properly, a control reaction is also 
set to compare them in agarose gel electrophoresis. The reaction is set as shown in 
Table 2.4. 
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Table 2.4: Control PCR reaction for bsLDH Q203L mutation. 
Content Volume 
Plasmid DNA template 2 µl 
Forward primer 1,25 µl 
Reverse primer 1,25 µl 
dNTP mix 1 µl 
Quick solution mix 3 µl 
Pfu polymerase 1 µl 
10x reaction buffer 5 µl 
ddH2O 35,5 µl 
Total reaction volume 50 µl 
 
PCR program for amplification is set as shown in Table 2.5. 
Table 2.5: PCR program for amplification. 
Segment Cycles Temperature Time 
1 1 95 1 min. 
2 18 
95 50 sec. 
60 50 sec. 
68 5 min 
3 1 68 7 min. 
 
2.2.4. Agarose gel electrophoresis 
To separate DNA fragments by their sizes agarose gel electrophoresis is used. In this 
project, 1 % agarose gels were used to estimate the size of DNA molecules following 
PCR reaction and restriction enzyme digestion.  
To prepare 1 % agarose gel : 
1g agarose was dissolved in 50 ml 1X TAE (Tris/Acetic Acid/EDTA) buffer. The 
agarose was solubilized by heating until the agarose was completely dissolved. Gel 
was cooled to ≤ 50ºC, then poured into a horizontal gel tray, and a comb for forming 
the sample slots was placed into the gel. Approximately 15 min later the gel was 
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solidified and then placed into an electrophoresis tank, where the gel was covered 
with 0,5X TAE buffer. The DNA was mixed with 6X Ez 
vision dye in the proportion of 5:1 and the sample was  
placed into a well on the agarose gel. For the fragment size control, Lambda  
DNA/EcoRI+Hind III Marker, 3 and Lambda DNA/Hind III Marker 2 were  
used. Electrophoretic separation was achieved by constant current at 100  
mV for 1 h. 
DNA within agarose gels were visualized under UV light. The size of the DNA was 
determined by comparing their mobility with the fragments of the DNA ladder. 
2.2.5. Dpn I digestion of the amplification products 
 Methylation of adenine and cytosine is part of the restriction modification system of 
many bacteria, in which specific DNA sequences are methylated periodically 
throughout the genome. A methylase is the enzyme that recognizes a specific 
sequence and methylates one of the bases in that sequence. Foreign DNAs (which are 
not methylated by this way) that are introduced into the cell are degraded by 
sequence-specific restriction enzymes and cleaved, while bacterial genomic DNA is 
not recognized by these restriction enzymes. The methylation of native DNA allows 
bacteria to protect themselves from infection by bacteriophages, thus acts as a sort of 
primitive immune system. E. coli DNA adenine methyltransferase (Dam) is an 
enzyme of ~32 kDa that does not belong to a restriction/modification system. E. 
coli Dam recognizes and targets GATC sequence, as the methylation occurs at the 
N6 position of the adenine in this sequence (G mATC). The three base pairs flanking 
each side of this site also influence DNA–Dam binding. Dam plays several 
significant roles in bacterial processes, including mismatch repair, the timing of 
DNA replication, and gene expression. As a result of DNA replication, the status of 
GATC sites in the E. coli genome changes from fully methylated to hemimethylated.  
Following temperature cycling, the product is treated with Dpn I. The Dpn I 
endonuclease (target sequence: 5´-Gm6ATC-3´) is specific for methylated and 
hemimethylated DNA and is used to digest the parental DNA template and to select 
for mutation containing synthesized DNA. DNA isolated from almost all E. coli 
strains is dam methylated and therefore susceptible to Dpn I digestion. 
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- 1 μl of the Dpn I restriction enzyme was added (10 U/μl) directly to each 
amplification reaction. 
-  Each reaction mixture was thoroughly mixed by pipetting the solution up and 
down several times. Reaction mixtures were spinned down in microcentrifuge for 1 
minute, then  the reactions were immediately incubated at 37°C for 1 hour to digest 
the parental (i.e., the nonmutated) supercoiled dsDNA. 
2.2.6. Bacterial strains  
BL21 competent E. coli genotype fhuA2 [lon] ompT gal [dcm] ΔhsdS were used in 
the study. 
2.2.7. Bacterial culture media 
LB medium was prepared by dissolving 10 g tryptone, 5 g yeast extract, and 10 g 
NaCl in 1 liter distilled water. The media was sterilized by autoclaving at 121oC for 
10 min. After sterilization, Amp. antibiotic was added to the LB medium as 0,1% 
concentration to the total volume in order to make selection media.  
LB- agar plate was prepared by adding 15 g/L of agar to LB medium and sterilized 
by autoclaving as described in LB medium. 
SOC medium was used to cultivate E. coli cells for 1 hour after heat shock during 
transformation. It was prepared by dissolving 2 g tryptone, 5 g yeast extract, 0.058 g 
NaCl, 0.0186 g KCl, 0.095 g MgCl2, 0.23g MgSO4 and 0.36 g glucose in 100 ml 
distilled water and sterilized at 121 °C with autoclaving for 10 min. 
2.2.8. Transformation of competent cells 
Both XL10-Gold ultracompetent cells (provided with the QuikChange® II XL Site-
Directed Mutagenesis Kit)  and laboratory-made (BL21 competent E. coli genotype 
fhuA2 [lon] ompT gal [dcm] ΔhsdS) competent cells were used to compare the 
efficiencies.  
Transformation is performed according to the QuikChange® II XL Site-Directed 
Mutagenesis Kit manual:  
Both strains were thawed gently on ice. 
For each control and sample reaction to be transformed, 45 μl of the ultracompetent 
cells were aliquotted to a prechilled Falcon® 2059 polypropylene tube. 2 μl of the β-
ME mix (provided with the kit) was added to the 45 μl of cells. Contents of the tube 
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were swirled gently. Cells were incubated on ice for 10 minutes, swirling gently 
every 2 minutes. 2 μl of the Dpn I-treated DNA from each control and sample 
reaction were transferred to separate aliquots of the ultracompetent cells. Heat-pulse 
was applied to the tubes in a 42°C thermoshaker for 30 seconds. Tubes were 
incubated on ice for 2 minutes. 0.5 ml of preheated (42°C) SOC medium was added 
to each tube, then the tubes were incubated at 37°C for 1 hour with shaking at 250 
rpm. 50 μl of each transformation reaction was plated on agar plates containing the 
Ampicilin antibiotic for the plasmid vector. 
For the mutagenesis and transformation controls, cells were spreat on LB–ampicillin 
agar plates containing 80 μg/ml X-gal and 20 mM IPTG. 
Transformation plates were incubated at 37°C for 16 hours. 
Process up to the plating of DNA samples are summarized in Figure 2.4. 
 
 
Figure 2.4: An overview of Quikchange site-directed mutagenesis method. 
2.2.9. Plasmid purification from bacterial cultures 
  The StrataPrep plasmid miniprep kit was used to purify plasmid DNA from bacterial 
cultures. The method employs a modification of the alkaline method of cell lysis and 
a microspin cup with a silica-based fiber matrix that binds DNA in the presence of a 
chaotropic salt. The sample is combined with a ribonuclease-containing solution, a 
cell lysis solution, and a DNA-binding solution and is then transferred to a microspin 
cup that is seated inside a receptacle tube. The plasmid DNA binds to the fiber 
matrix in the microspin cup. The contaminants are then washed from the microspin 
cup with a wash buffer. The purified plasmid DNA is eluted from the fiber matrix 
with a low-ionic-strength buffer and captured in a microcentrifuge tube. The result is 
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purified plasmid DNA that is ready for restriction digestion, ligation, and sequencing 
reactions. Following steps are realized in order to obtain this purified plasmid: 
 
A culture medium of 5ml with a single bacterial colony was inoculated and 5 µl 
Amp. was added. Cell culture was incubated 20 hours at 37°C with vigorous shaking. 
1.5 ml of the cell culture was aliquotted into a 1.5-ml microcentrifuge tube. Tubes 
were spinned in microcentrifuge at maximum speed for 1 minute. After 
centrifugation, supernatant was removed and discarded. 100 μl of solution 1 was 
added to the microcentrifuge tubes. The tubes was vortexed to resuspend the cell–
solution 1 mixture and completely disperse the cells. 100 μl of solution 2 was added 
to the microcentrifuge tubes. The contents were mixed by inverting the tube several 
times. 125 μl of solution 3 was added to the microcentrifuge tubes. Contents were 
mixed by inverting the tubes several times. Tubes were spinned in a microcentrifuge 
at maximum speed for 5 min. Supernatants were decanted.  The caps of the 2-ml 
receptacle tubes were snapped onto the top of the microspin cup. Pellets and the 
microcentrifuge tubes were discarded. The samples were spinned in a 
microcentrifuge at maximum speed for 30 sec. The caps of the 2-ml receptacle tubes 
were opened, microspin cups were removed from the receptacle tubes, and the 
liquids were discarded.  Microspin cups were replaced in the receptacle tube. 
 
Endonucleases from the samples were washed according to the following protocol: 
 
750μl of nuclease-removal buffer was added to the microspin cup. The cap of the2ml 
receptacle tube was snapped onto the top of the microspin cup. The sample was 
spinned in a microcentrifuge at maximum speed for 30 sec. The filtrate in the 
microcentrifuge tube was discarded. The microspin cup was placed back in the 2-ml 
receptacle tube and snap the cap of the receptacle tube onto the top of the microspin 
cup. Sample was spinned in a microcentrifuge at maximum speed for an additional 
30 seconds. The microspin cup was removed and the filtrate was discarded. 750 μl of 
1× wash buffer ( prepared with adding the equal amount of 100% ethanol to the stock 
washing buffer) was added to the microspin cup. Sample was spinned in a 
microcentrifuge at maximum speed for 30 seconds. The microspin cup was removed 
and the filtrate was discarded. The sample was spinned in a microcentrifuge at 
maximum speed for an additional 30 sec. The microspin cup was transferred to a 
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fresh 1.5 ml tube. 50 μl of elution buffer was loaded directly on top of the fiber 
matrix at the bottom of the microspin cup. The sample was incubated at room 
temperature for 5 minutes. Then, the sample was in a microcentrifuge at maximum 
speed for 30 seconds. Microspin cup was discarded and the eluted DNA was 
obtained. 
2.2.10. Determination of DNA concentration  
Recovery, purity and concentration of nucleic acids were determined 
spectrophotometrically with NanoDrop 2000. The ratio of absorptions at 260 nm vs 
280 nm is commonly used to evaluate the purity of DNA with respect to protein 
contamination, since protein (in particular, the aromatic amino acids) tends to absorb 
light at 280 nm. The ratio of absorbance (A260/A280) of a pure DNA solution is 
between 1.8 and 2.0. As protein contamination increases, the ratio decreases. 
2.2.11.Identifying the mutated regions 
DNA samples obtained from bacterial cell recovery are subjected to DNA 
sequencing. 
2.2.12. Obtaining the WT and mutated cells from colonies 
Glycerol stocks had been prepared from small scale cultures (10 mL) previously. 
To obtain small scale culture again, 10ul glycerol stock ingredient was added to 10 
ml LB+Amp. This mixture was growth overnight at 37oC. The following day, this 
culture was added to 1L. LB+Amp. After ~ 3 h. later, when the OD600 value of the 
culture reached 0.6, the gene expression of the bacteria was induced by  1mM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG).  
IPTG  is an analog of lactose that inactivates the lac repressor. IPTG serves as a 
mimic of the naturally occurring allolactose that is an inducer of the lac operon.  
IPTG induction is commonly used in protein expression. 
After 4h. of IPTG induction, samples were centrifuged at 5000 rpm for 20 min. to 
extract cells from growth medium.  
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2.2.13. Enzyme purification from bacterial cells 
Both WT and mutated cells obtained by centrifugation were dispersed in lysis buffer 
+ lysozyme mixture (1mg lysozyme per 1ml lysis buffer). This mixture was chilled 
on ice for 20 min. After that, the samples were subjected to sonication for 2 min. by 
10 sec on/20 sec off intervals. To remove the cellular debris, samples were 
centrifuged at 10.000 g for 10 min. To each supernatant (obtained from 250 mL 
culture), 500uL Ni-NTA resin was added to attach our His-tagged protein.  
2.2.14. The 6xHis tag purification of enzyme 
The most commonly used tag for collecting large amounts of highly purified protein 
is a poly-histidine tag (His-tag). It comprises 6 – 14 histidines and is typically fused 
to the N- or C-terminal end of a target protein. In some cases, the tag can also be 
inserted into an exposed loop of the target protein. The imidazole side chains of a 
His-tag can engage inreversible coordinative bonds to certain transition metal ions, 
such as Ni2+, Co2+, or Zn2+, respectively. 
Ni2+ shows the highest affinity and selectivity for His-tags and is therefore 
preferred. Using certain chelators covalently linked to a matrix, Ni2+ can be 
immobilized in a way that still allows the Ni2+ ion to interact with histidine side 
chains. When His-tagged proteins are applied to this Ni2+ matrix, they specifically 
bind to the resin, while most untagged proteins do not. Bound proteins can be 
released from the matrix using mild conditions. Imidazole competes for coordination 
sites on Ni2+ displacing His-tagged proteins from the matrix. Alternatively, lowering 
pH will protonate His-tags and hence also elute the His-tagged proteins. 
Ni-NTA system 
Nitrilotriacetic acid (NTA), is a tetradentate chelating adsorbent developed at 
Hoffmann-La Roche that overcomes these problems. NTA occupies four of the six 
ligand binding sites in the coordination sphere of the nickel ion, leaving two sites 
free to interact with the 6xHis tag as shown in Figures 2.5 and 2.6. NTA binds metal 
ions far more stably than other available chelating resins (Hochuli, 1989) and retains 
the ions under a wide variety of conditions, especially under stringent wash 
conditions. The NTA matrices can therefore bind 6xHis-tagged proteins more tightly 
than IDA matrices, allowing the purification of proteins from less than 1% of the 
total protein preparation to more than 95% homogeneity in just one step (Janknecht 
et al., 1991). 
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Figure 2.5: Interaction between neighboring residues in the 6xHis tag and Ni-NTA 
                    matrix. 
 
Figure 2.6: Interaction of NTA chelate matrice with nickel ion. 
Ni-NTA agarose added samples were incubated at 4oC for 40 min.  After 40 min, 
samples were centrifuged at 4000 g for 5 min. The supernatant was taken to  be 
analysed in SDS-PAGE. The resin-binded protein was washed 3 times with 750 uL  
wash buffer   , in each step centrifuging at 4000 g for 1 min. These washed samples 
were collected and labeled as W1, W2 and W3, again to analyse in SDS-PAGE.  
After washing steps, elution  was realized 3 times  by 250 uL elution  buffer 
centrifuging at 4000 g for 1 min every time. after each step, the supernatants were 
taken and labeled as E1, E2 and E3. 
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Lysis buffer (1 liter): 
50 mM NaH2PO4   6.90 g NaH2PO4·H2O (MW 137.99 g/mol) 
300 mM NaCl   17.54 g NaCl (MW 58.44 g/mol) 
10 mM imidazole   0.68 g imidazole (MW 68.08 g/mol) 
pH adjusted to 8.0 using NaOH. 
Wash buffer (1 liter): 
50 mM NaH2PO4   6.90 g NaH2PO4·H2O (MW 137.99 g/mol) 
300 mM NaCl   17.54 g NaCl (MW 58.44 g/mol) 
20 mM imidazole   1.36 g imidazole (MW 68.08 g/mol) 
pH adjusted to 8.0 using NaOH. 
Elution buffer (1 liter): 
50 mM NaH2PO4   6.90 g NaH2PO4·H2O (MW 137.99 g/mol) 
300 mM NaCl   17.54 g NaCl (MW 58.44 g/mol) 
250 mM imidazole   17.00 g imidazole (MW 68.08 g/mol) 
pH adjusted to 8.0 using NaOH. 
2.2.15. SDS-PAGE  analysis of the purified protein 
SDS-PAGE separates proteins primarily by mass because the ionic detergent sodium 
dodecyl sulfate (SDS) denatures and binds to proteins to make them evenly 
negatively charged. Thus, when a current is applied, all SDS-bound proteins in a 
sample will migrate through the gel toward the positively charged electrode. Proteins 
with less mass travel more quickly through the gel than those with greater mass 
because of the sifting effect of the gel matrix. Once separated by electrophoresis, 
proteins can be detected in a gel with various stains, transferred onto a membrane for 
detection by Western blotting and/or excised and extracted for analysis by mass 
spectrometry. 
To obtain optimal resolution of proteins, a stacking gel is cast over the top of the 
resolving gel. The stacking gel has a lower concentration of acrylamide, lower pH 
and a different ionic content. This allows the proteins in a loaded sample to be 
concentrated into a tight band during the first few minutes of electrophoresis before 
entering the resolving portion of a gel. A stacking gel is not necessary when using a 
gradient gel, as the gradient itself performs this function. 
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The SDS gels were prepared as shown in Table 2.6. 
      Table 2.6: Ingredients of SDS gel used in the study. 
 Resolving gel 
(12%) 
Stacking gel 
(5%) 
dH2O 2 mL 1.4 mL 
40% Acrylamide 1.5 mL 0.25 mL 
1.5 M Tris (pH 8,8) 1.3 mL - 
1 M Tris (pH 6,8) - 0.25 mL 
10% SDS 0.05 mL 0.02 mL 
APS (10%) 100 uL 50 uL 
TEMED 10 uL 5 uL 
 
Samples were loaded into the gel with 5X Laemmli buffer (1uL laemmli buffer per 5 
uL sample). Proteins were denatured at 95oC for 15 min, and the marker for 5 min. 
Fermentas Unstained Protein Molecular weight marker (SM0431) was used to 
determine protein range.  
The gel was run at 120 V for 1 h. Then, the gel (resolving part) was taken into a 
container with Coomassie blue for staining and incubated at RT on a shaker 
overnight.  
The day after, the gel was conveyed to destaining solution and incubated on the 
shaker at RT for 45 min. When destaining was complete, the gel was visioned using 
densitometer. 
2.2.16. Ultrafiltration of the eluted protein 
Ultrafiltration is a method to concentrate protein or other macromolecules through a 
membrane with defined pores. The membranes used in this system have a molecular 
weight cut-off (MWCO) which is the limit of size (or range) of a protein that can 
pass through the membrane. Each membrane also has a chemical characteristic for 
binding proteins and stability in various solvents. There are two main methods to 
force the protein containing fluid through the membrane, pressure from an inert gas  
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or centrifugal force. Larger volumes are more suited to the pressure stirred cells. For 
smaller volumes the centrifugal devices are easier and more practical to use. In 
centrifugation, the hydrostatic pressure during centrifugation forces the fluid through 
the membrane. Proteins larger than the MWCO are retained and the smaller 
molecules, like the salts, buffers, water and small proteins pass through. 
Ultrafiltration was realized using centrifugal ultrafiltration tubes of MWCO size 
30.000 Da. Eluted protein (E3) was solved in 10 mL 50mM Tris-HCl Buffer pH 7.4. 
To obtain ~1000 uL ultrafiltered protein, the mixture was centrifuged at 2000 rpm for 
20 min. Then, the protein was aliquotted into 2 mL centrifuge tubes for further use. 
2.2.17. Indication of enzyme concentration  
Enzyme concentration was measured using Microplate Spectrophotometer. Bovine 
Serum Albumin (BSA) of determined concentrations were used to assess the 
unknown concentrations. To realize this, 5 uL of protein and 195 uL Bradford 
reagent were used for each well. 
2.2.18. Kinetic measurements  
All steady-state kinetic parameters were measured from the decrease in extinction at 
340 nm at 25oC in 50 mM Tris buffer pH 7.4. Various substrate concentrations were 
used both in WT and mutant enzymes. 0.2 mM NADH and 5 nM bsLDH were used 
in each reaction in the absence or presence of FBP (5 mM).  
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3.  RESULTS & DISCUSSION 
3.1. Cloning the insert into pQE2 vector 
To form the Q203L mutation in bsLDH gene sequence, PCR was realized with the 
appropriate primers. In order to ensure that the plasmid carries the desired insert, 
Dpn I-digested and non-digested samples were run by agarose gel electrophoresis. 
Electrophoresis result is shown in Figure 3.1. DNA fragment of interest is visualized 
at ~5600 bp region, as the pQE vector is 4.8 kbp and bsLDH sequence is ~800 bp 
long. 
 
Figure 3.1: Agarose gel image of both Dpn I digested and non-digested samples. 
3.2. Obtaining colonies following transformation  
Following transformation of Dpn I digested and control DNA samples, plates were 
incubated at 37oC overnight.  16h. later, the plates are taken from 37oC. As shown in 
Figure 3.2 , transformation with XL10-Gold® ultracompetent cells was more 
effective than transformation with BL-21 strain, as higher amounts of colonies are 
obtained from β-mer plate. 
5600 bp 
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Figure 3.2: Colonies formed following transformation of Dpn I digested DNA 
                   a: in BL-21 competent cell strain, b: in XL10-Gold® ultracompetent 
                   cells. 
3.3. Sequencing the plasmid with bsLDH gene to demonstrate the correct 
mutations 
After obtaining colonies from both plates, plasmid DNA purification was realized. 
According to the sequencing data, the mutations were verified to be correct as shown 
in Figures 3.3, 3.4 and 3.5. 
 
Figure 3.3: Mutation in Q102R position in bsLDH. 
 
 
Figure 3.4: Mutation in Q203L position in bsLDH. 
a b 
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        W1     W2       W3                   E1       E1        E2      E3 
 
Figure 3.5: Absorbance data of Q203L mutation in bsLDH. 
3.4.    Determination of the Purified Enzyme 
Following lysis, washing and elution steps, obtained protein mix was subjected to 
SDS-PAGE analysis in order to determine the presence of bsLDH enzyme which is 
35 kDa in molecular mass. WT and mutant proteins were investigated for both wash 
and elution steps. SDS-PAGE image of the WT and mutant enzymes are given in 
Figure 3.6 and 3.7 respectively.  
 
 
 
 
 
 Figure 3.6 : SDS-PAGE result of the wild type bsLDH (W: successive  
                                    washing steps ; E : succesive elution steps). 
 
 
 
 
35kDa 
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                           E3           E2                  E1        W3         W2        W1 
 Figure 3.7: SDS-PAGE result of the mutant bsLDH (W: successive  
                               washing steps; E : succesive elution steps). 
3.5. Indication of Enzyme Concentration After Ultrafiltration 
Enzyme concentrations were found out to be 0.538 mg/mL for WT and 0.217 mg/mL 
for mutant proteins. Ingredients were calculated as to correspond to 0.2 mM NADH, 
5 nM bsLDH and 5mM FBP in a total reaction volume of 1mL. 
3.6. Kinetic Measurements 
Absorbance data at 340 nm of WT and mutant enzymes are given in Table 3.1. Rates 
were calculated subtracting the t1 (1.min) value from t0 (data recorded as soon as 
placing the reaction cuvette) value.  
The steady-state catalytic properties of WT and mutant enzymes were measured at 
25oC by spectrophotometer in the absence and presence of FBP. Vmax and Km 
values were calculated by GraFit 7 software programme along with the Michaelis-
Menten and Lineweaver-Burk plots. 
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                Table 3.1: Rates of WT and mutant enzymes according to various  
                                  pyruvate concentrations 
 WT Mutant 
Pyruvate 
concentration 
- - FBP + FBP - - FBP + FBP 
0,01mM 0,0310 0,0120 0,0741 0,0978 
0,02 mM 0,0223 0,1428 0,0280 0,0442 
0,04 mM 0,0257 0,1491 0,0259 0,0873 
0,06 mM 0,2038 0,1439 0,0005 0,0702 
0,08 mM 0,0036 0,0745 0,0007 0,0014 
0,1 mM 0,1233 0,2225 0,0027 0,0029 
0,15 mM 0,2340 0,0120 0,0104 0,2165 
0,2 mM 0,2883 0,2937 0,0000 0,0168 
0,25 mM 0,2225 0,2774 0,0145 0,0595 
Kinetic data of bsLDH native and mutants with different substrates are shown in 
Table 3.2. In this table, Vmax, Km and Kcat values of wild type and single mutants 
are given from the reference studies. Also, the double mutant data, which is the 
subject of our work is included with its correlated WT to comparatively evaluate 
both the effect of FBP and the how the function of the enzyme alters as shifted from 
native enzyme to various mutant types. Because the Q203L mutation causes the 
enzyme to work almost in a fully activated way in the absence of FBP, but not an 
increase in substrate specificity, there is no data for Q203L in oxaloacetate and α-
keto malonate sections. Here, the Vmax, Km and Kcat values obtained in our work 
for WT and mutant enzymes, using pyruvate, the natural substrate of the enzyme, are 
shown in “WT bsLDH *** with FBP” part. As we did not observe any activity 
without FBP, this part is stated as ND, not detected. Regions indicated as ---, belongs 
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to the ongoing experiments made by using oxaloacetate and α-ketomalonate. By 
completion of these data, the kinetic behaviour of bsLDH Q102R and Q203L double 
mutant through diversified substrates and FBP need will be elucidated. 
As an example for WT with FBP kcat was calculated as follows: 
Km = 0.0597 mM               Vmax = 0.3559 sec-1 
A = ε. C. I                                                                                                            (3.1) 
I = 1 cm       ε NADH = 6220  0.3559 = 6220. C. 1          ΔC =  6 x 10 -5      
kcat = 6 x 10 
-5 / 5 x 10 -9 = 12000 sec -1 
Similar calculations will be performed for ongoing experiments with oxaloacetate 
and α-keto malonate substrates. 
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Table 3.2: Kinetic parameters of native, Q102R mutant, Q203L mutant and Q102R&Q203L  
                  double mutant enzymes with various substrates in the absence/presence of FBP. 
 
Enzyme Substrate 
 
Pyruvate Oxaloacetate 
+FBP -FBP +FBP -FBP 
Vmax Km (mM) K cat (s-1) Vmax Km (mM) K cat (s-1) Vmax Km (mM) K cat (s-1) Vmax Km (mM) K cat (s-1) 
Wt 
bsLDH
* 
 
0.062
±0.004 
140±3  2.7±0.17 240±3  3.42±0.02 6.3±0.05  4.1±0.2 6.1±0.3 
Q102R
* 
 2.1±0.01 1.1±0.3  1.9±0.1 
0.89
±0.06 
 
0.06
±0.003 
253±3  
0.062
±0.003 
234±2 
Q203L 
** 
 0.05 30  0.07 36   
Q102R
+Q203
L *** 
ND ND ND ND ND ND --- --- --- --- --- --- 
Wt 
bsLDH 
*** 
0.3559 0.0597 12000 ND ND ND --- --- --- --- --- --- 
 
*  data taken from Binay et al., 2009 
** data taken from Allen and Holbrook, 2000 
*** data obtained by this work 
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Table 3.2 (cont’d): Kinetic parameters of native, Q102R mutant, Q203L mutant and  
                                            Q102R&Q203L double mutant enzymes with various substrates  
               in the absence/presence of FBP. 
 
Enzyme Substrate 
 
α -ketomalonate 
+FBP -FBP 
Vmax Km (mM) K cat (s-1) Vmax Km(mM) K cat(s-1) 
Wt 
bsLDH
* 
 70±2 2.13±0.07  18.8±1.4 1.5±0.01 
Q102R
* 
 3.2±0.2 244±4  3.0±0.2 223±3 
Q102R
+Q203
L *** 
--- --- --- --- --- --- 
Wt 
bsLDH
*** 
--- --- --- --- --- --- 
 
* data taken from Binay et al., 2009 
*** data obtained by this work 
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4.  CONCLUSION 
bsLDH is a commercially substantial enzyme owing to its use in industry to produce 
agrochemicals and pharmaceuticals. The technical enzymes including these groups 
comprise 65% of the worldwide industrial enzyme market. On the other hand, 
enzymes are being more and more popular against their synthetic equivalents by their 
advantages of biodegradability, being derived from renewable sources and ability to 
work under milder pH and temperature conditions. Considering these factors 
together, bsLDH is worth being interested in from the protein engineering point of 
view. 
Moreover, bsLDH has some limiting features which makes it difficult to use in  
industry such as: 
 Narrow substrate range 
 Activation by an expensive activator, FBP 
 Substrate inhibition : being inhibited by excess amount of pyruvate/lactate 
All these disadvantegous properties, from the other side, make bsLDH enzyme an 
appropriate target for protein engineering. 
Previous studies on bsLDH sequence showed that Q102R single residue mutation 
gives rise to a switch in substrate specificity by three orders of magnitude from 
lactate to malate (Wilks et al., 1988).  
On the other hand, a bsLDH mutant carrying 3 amino acid substitutions, one of 
which is  Q203L alteration, was found out to be almost fully activated in the absence 
of the natural activator, FBP (Allen and Holbrook, 2000). This shift is most likely be 
caused by this particular residue as it is found in the dimer-dimer interface of the 
gene sequence. 
In light of this information, by this work, it is aimed to investigate the double mutant 
(Q102R and Q203L) effect on both substrate specificity and activator requirement 
and to inquire into the kinetic behaviour of the newly formed enzyme by using 
rational design methods. In order to accomplish the work, Q102R and Q203L 
mutants were constituted by site-directed mutagenesis in bsLDH sequence which 
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was found in pQE2 vector. To be used in the PCR reaction, appropriate 
oligonucleotides were designed to generate Q102R and Q203L mutations. Following 
the PCR with these oligos, mutant dsDNAs were selected by Dpn I digestion. . After 
that, mutated DNA was transformed into E.coli competent cells. Plasmid DNA was 
purified following the transformation and samples were controlled to ensure to have 
achieved the correct mutations. After confirming to form Q102R and Q203L 
mutations in bsLDH sequence, mutated DNA was amplified in large-scale E.coli 
culture. The culture was precipitated in order to obtain protein from cells. Desired 
protein with 6xHis-tag was sorted from the protein pool by Ni-NTA resin system 
which selectively binds His-tagged proteins. Thereafter, by SDS-PAGE, the protein 
was visualized at the region of its molecular mass (35kDa) and have ensured to 
obtain the enzyme. By ultrafiltration, smaller proteins and other contaminants were 
removed and a purer enzyme was attained. 
Completing kinetic measurements, the Km value of the WT enzyme in the presence 
of FBP was found to be 0,0597 mM using pyruvate as substrate consistent with the 
mentioned data (Allen & Holbrook, 2000; Km = 0,05mM). However, no detectable 
data could be obtained from our double mutant when subjected to kinetic 
measurements with pyruvate. Actually this phenomenon is consistent with the 
Q102R mutant enzyme feature : functioning as a malate dehydrogenase. Moreover, 
obtaining the WT data similar to the reference study implies that the mutant works 
correctly. 
To further investigate the double mutant effect (Q102R and Q203L) on bsLDH 
sequence, additional studies will be carried on analyzing the kinetic parameters using 
oxaloacetate and alpha keto malonate as substrates both in the absence and presence 
of FBP. Also, these information will enlighten the contribution of the mutation to the 
activator requirement. 
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APPENDICES 
 
APPENDIX A: Amino asid abbreviations 
 
 
Figure A.1: Amino asid abbreviations. 
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